- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Abraxane
Total 528 results
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPatients With Stage IV or Recurrent Adenocarcinoma of the Lung
-
Eli Lilly and CompanyCelgeneCompletedCarcinoma, Non-Small Cell Lung Cancer (NSCLC)United States
-
University of Texas Southwestern Medical CenterTerminatedBreast CancerUnited States
-
Loyola UniversityGenentech, Inc.; Celgene CorporationCompletedBreast CancerUnited States
-
Sumitomo Pharma America, Inc.CompletedCarcinoma, Pancreatic DuctalUnited States, France, Netherlands, Spain, Taiwan, China, Belgium, Korea, Republic of, Austria, Singapore, Japan, Italy, Germany, Portugal, Poland, Czechia, Australia, Canada, Russian Federation, Ukraine
-
Brown UniversityRhode Island HospitalCompletedPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMelanoma | Liver MetastasisUnited States
-
The Cleveland ClinicCompleted
-
IRCCS San RaffaeleBristol-Myers SquibbRecruiting
-
Chinese PLA General HospitalUnknownAdvanced Pancreatic CancerChina
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
Yale UniversityAgennixCompletedAdvanced CancersUnited States
-
Sun Yat-sen UniversityRecruitingAngiosarcoma MetastaticChina
-
University Health Network, TorontoActive, not recruiting
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Precancerous ConditionUnited States
-
University of Texas Southwestern Medical CenterCompletedHead and Neck CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted
-
Australasian Gastro-Intestinal Trials GroupUniversity of SydneyActive, not recruitingPancreatic Ductal Adenocarcinoma | Metastatic Pancreatic CancerAustralia, New Zealand
-
AIPING ZHOUCompletedAdvanced Pancreatic CancerChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Cervical Small Cell CarcinomaUnited States
-
Washington University School of MedicineCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownNAFLD | Pre-diabetesMexico
-
Loyola UniversityKaryopharm Therapeutics IncRecruitingOvarian CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownUterine Cervical CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMuscle-Invasive Bladder CarcinomaItaly
-
Case Comprehensive Cancer CenterCompletedMetastatic Triple Negative Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustBoehringer Ingelheim; CelgeneWithdrawnAdenocarcinoma of Lung | NSCLC, Recurrent
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
-
Cancer Institute and Hospital, Chinese Academy...Terminated
-
Medical University of South CarolinaTerminatedAdenocarcinoma PancreasUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedLung CancerUnited States
-
Chinese PLA General HospitalZhejiang UniversityRecruitingLymphoma | Solid Tumor, Adult | EphA2 Overexpression | TP53 R273H | TP53 R175H | TP53 R248Q | TP53 R249SChina
-
Chinese PLA General HospitalZhejiang UniversityRecruitingSolid Tumor, Adult | KRAS G12D | EphA2 Overexpression | KRAS G12V | KRAS G12CChina
-
Theriva Biologics SLCompletedPancreatic Adenocarcinoma | Locally Advanced Solid Tumors | Metastatic Solid TumorsSpain
-
Abramson Cancer Center of the University of PennsylvaniaHalozyme TherapeuticsWithdrawnPancreatic Ductal AdenocarcinomaUnited States
-
CelgeneCompletedNon-Small Cell Lung CarcinomaUnited States, Canada
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedPancreatic CancerAustralia, New Zealand, Spain
-
VCN Biosciences, S.L.CompletedPancreatic Adenocarcinoma | Metastatic Pancreatic AdenocarcinomaSpain
-
University of California, IrvineTerminatedHead and Neck CancerUnited States
-
University of Texas Southwestern Medical CenterCelgeneCompletedSTAGE IIIA/B NSCLC / INOPERABLE LUNG CANCERUnited States
-
Dana-Farber Cancer InstituteStand Up To Cancer; American Association for Cancer Research; Lustgarten FoundationActive, not recruitingPancreatic CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B; North...CompletedLung Cancer | Radiation ToxicityUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedPancreatic CancerUnited States, Canada, United Kingdom, Spain, Australia, Belgium
-
Azienda Sanitaria ASL Avellino 2CompletedCardiovascular MortalityItaly
-
Columbia UniversityGenentech, Inc.; Celgene CorporationCompletedCarcinoma, Non-Small-Cell LungUnited States